title: Recurrent group B streptococcal disease in infants: Who should receive rifampin?
abstract: A preterm breast-fed infant had three episodes of type Ia/c group B streptococcus septicemia. After the second episode rifampin was given to the infant, but further Ia/c exposure to maternal breast milk ensued. We propose rifampin treatment for both the mother and infant in cases of recurrent group B streptococcus disease.
authors.affiliation: Department of Pediatrics, The University of Texas Health Science Center, Houston, USA.
authors.forename: J T
authors.initials: JT
authors.lastname: Atkins
authors.forename: G P
authors.initials: GP
authors.lastname: Heresi
authors.forename: T M
authors.initials: TM
authors.lastname: Coque
authors.forename: C J
authors.initials: CJ
authors.lastname: Baker
mesh_terms: D001942:Breast Feeding; D016521:Electrophoresis, Gel, Pulsed-Field; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007917:Leprostatic Agents / Q000627:therapeutic use*; D008895:Milk, Human / Q000382:microbiology*; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013292:Streptococcus agalactiae / Q000302:isolation & purification*
chemical_list: D007917:Leprostatic Agents; D012293:Rifampin